Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
This clinical trial update reports on the effectiveness and safety of ONUREG (oral azacitidine) in Chinese patients with acute myeloid leuke…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
A Phase 1b/2a clinical trial evaluating Nadunolimab in combination with azacitidine, with or without venetoclax, for myelodysplastic syndrom…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy [Phase 2]
A Phase 2 trial is evaluating the combination of tagraxofusp with venetoclax and azacitidine in adults with untreated CD123+ acute myeloid l…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Role of Adrenomedullin in Leukemic Endosteal/Vascular Niches [NA]
This clinical trial update examines the role of adrenomedullin in the leukemic endosteal and vascular niches in acute myeloid leukemia. The …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting [Phase 2]
This clinical trial update describes a Phase 2 study of venetoclax plus azacitidine for acute myeloid leukemia in the post-transplant settin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients [Phase 2]
A Phase 2 trial evaluating selinexor in combination with induction/consolidation therapy for untreated adult acute myeloid leukemia; the stu…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial at Memorial Sloan Kettering Cancer Center is evaluating a combination of Ivosidenib, Azacitidine, and Venetoclax fo…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
A clinical trial update notes a study evaluating chemotherapy-induced cognitive disorders in patients treated for hematological malignancies…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker [Phase 2]
This Phase 2 trial compares hypomethylating agents to intensive chemotherapy in Acute Myeloid Leukemia, using 5hmC as a blood-based minimal …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial evaluating a CD33-targeted CAR T cell therapy for recurrent or refractory acute myeloid leukemia, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
Clinical trial update from University Health Network, Toronto evaluating the risk of myelodysplastic syndrome and acute myeloid leukemia in …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant [Phase 1]
Phase 1 clinical trial update evaluating maintenance therapy with tagraxofusp and azacitidine in CD123-positive acute myeloid leukemia and m…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent [Phase 2]
This Phase 2 trial evaluates olutasidenib plus azacitidine, followed by olutasidenib maintenance, for IDH1-mutated acute myeloid leukemia in…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation [Phase 2]
Phase 2 trial update on enasidenib with azacitidine for recurrent or refractory acute myeloid leukemia with IDH2 mutation, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors [EARLY_Phase 1]
An early-phase trial is exploring anti-leukemia immune responses after irradiation of extramedullary tumors in patients with acute myeloid l…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant [Phase 1]
A Phase 1 clinical trial update assessing olutasidenib for IDH1-mutated acute myeloid leukemia, myelodysplastic syndrome, or chronic myelomo…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study of BL-M11D1 in combination with cytarabine plus daunorubicin or venetoclax plus…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory [Phase 1]
A Phase 1 clinical trial evaluating pembrolizumab plus decitabine, with or without venetoclax, for patients with acute myeloid leukemia or m…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
This ongoing Phase 1/2 clinical trial is evaluating venetoclax in combination chemotherapy for newly diagnosed or relapsed/refractory acute …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant [Phase 1]
A Phase 1 clinical trial evaluating Revumenib for acute leukemia in patients after allogeneic stem cell transplant; the study is currently r…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML [Phase 1, Phase 2]
A Phase 1/2 trial evaluating venetoclax with hypomethylating agents and subcutaneous cytarabine in patients with CEBPA-mutated acute myeloid…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors
A pediatric cancer survivor study focusing on symptom cluster heterogeneity and gut microbiota mechanisms is currently recruiting, including…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]
This Phase 1 trial tests a triple-drug regimen of Revumenib, azacitidine, and venetoclax in pediatric and young adult patients with refracto…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
A Phase 1b/2 open-label study is evaluating the safety and efficacy of oral cladribine in patients with acute myeloid leukemia, with the tri…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial update for a first-line combination of gilteritinib, venetoclax, and azacitidine in newly diagnosed acute myeloid leukemia, i…